These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2190398)

  • 1. Summary on therapeutic drug monitoring for renal transplantation.
    Kahan BD
    Transplant Proc; 1990 Jun; 22(3):1348-51. PubMed ID: 2190398
    [No Abstract]   [Full Text] [Related]  

  • 2. Steady-state concentrations of cyclosporine for therapeutic monitoring.
    Grevel J; Napoli KL; Kahan BD
    Transplant Proc; 1990 Jun; 22(3):1339-42. PubMed ID: 2190397
    [No Abstract]   [Full Text] [Related]  

  • 3. Nonselective measurement of cyclosporine for therapeutic drug monitoring by fluorescence polarization immunoassay with a sheep polyclonal antibody: II. Evaluation of the whole blood methodology and comparison with an 3H tracer-mediated radioimmunoassay with a sheep polyclonal antibody.
    Napoli KL; Kahan BD
    Transplant Proc; 1990 Jun; 22(3):1181-5. PubMed ID: 2190378
    [No Abstract]   [Full Text] [Related]  

  • 4. Consensus document: Hawk's Cay meeting on therapeutic drug monitoring of cyclosporine.
    Transplant Proc; 1990 Jun; 22(3):1357-61. PubMed ID: 2190399
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical evaluation and therapeutic range of cyclosporine A as monitored by FPIA in kidney transplantation.
    Nattermann U; Steimer W; Gokel JM; Seidel D; Land W
    Transplant Proc; 1990 Jun; 22(3):1284-6. PubMed ID: 2190391
    [No Abstract]   [Full Text] [Related]  

  • 6. Japanese conference on cyclosporine blood level monitoring.
    Takagi H; Uchida K
    Transplant Proc; 1990 Jun; 22(3):1224-5. PubMed ID: 2190384
    [No Abstract]   [Full Text] [Related]  

  • 7. Failure of 125I-tracer selective monoclonal antibody levels on a whole blood matrix to predict rejection or nephrotoxic episodes in renal transplant patients under anti-lymphocyte globulin and prednisone therapy.
    Stiller C; Keown P
    Transplant Proc; 1990 Jun; 22(3):1253-4. PubMed ID: 2349687
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical correlations of cyclosporine HPLC and FPIA levels in renal transplant recipients.
    Sridhar N; Schroeder TJ; Pesce AJ; First MR
    Transplant Proc; 1990 Jun; 22(3):1257-9. PubMed ID: 2190387
    [No Abstract]   [Full Text] [Related]  

  • 9. A prospective study of cyclosporine monitoring in renal transplantation.
    Lindholm A
    Transplant Proc; 1990 Jun; 22(3):1260-3. PubMed ID: 2190388
    [No Abstract]   [Full Text] [Related]  

  • 10. Quality assessment of cyclosporine measurements: comparison of current methods.
    Holt DW; Marsden JT; Johnston A
    Transplant Proc; 1990 Jun; 22(3):1234-9. PubMed ID: 2190385
    [No Abstract]   [Full Text] [Related]  

  • 11. French multicentre study: comparison of two specific and four nonspecific methods for Sandimmune (cyclosporine) blood and plasma (separated at 37 degrees C or at 22 degrees C) monitoring.
    Vernillet L; Humbert H; Aupetit B; Berard M; Bertault-Peres P; Billaud E; Bizollon CA; Breteau M; Brisson AM; Codet JP
    Transplant Proc; 1990 Jun; 22(3):1218-23. PubMed ID: 2190383
    [No Abstract]   [Full Text] [Related]  

  • 12. An evaluation of cyclosporine monitoring by nonselective fluorescence polarization immunoassay.
    Pesce AJ; Schroeder TJ; First MR
    Transplant Proc; 1990 Jun; 22(3):1171-4. PubMed ID: 2190376
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of the utility of 3H-based specific monoclonal antibody assay on whole blood samples with the fluorescence polarization nonspecific immunoassay on serum samples for diagnosis of adverse events in renal transplant patients.
    Kahan BD; Napoli K; Welsh M; Grevel J; Rutzky LP
    Transplant Proc; 1990 Jun; 22(3):1274-9. PubMed ID: 2190389
    [No Abstract]   [Full Text] [Related]  

  • 14. Monitoring of cyclosporine by serial posttransplant pharmacokinetic studies in renal transplant patients.
    Awni WM; Heim-Duthoy K; Kasiske BL
    Transplant Proc; 1990 Jun; 22(3):1343-4. PubMed ID: 2349693
    [No Abstract]   [Full Text] [Related]  

  • 15. Nonselective measurement of cyclosporine for therapeutic drug monitoring by fluorescence polarization immunoassay with a rabbit polyclonal antibody: I. Evaluation of the serum methodology and comparison with a sheep polyclonal antibody in an 3H-tracer mediated radioimmunoassay.
    Napoli KL; Kahan BD
    Transplant Proc; 1990 Jun; 22(3):1175-80. PubMed ID: 2190377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality assessment of cyclosporine monitoring--Canadian validations.
    Wong PY; Mee AV; Glenn J; Keown PA
    Transplant Proc; 1990 Jun; 22(3):1216-7. PubMed ID: 2349683
    [No Abstract]   [Full Text] [Related]  

  • 17. Performance of the Sandoz radioimmunoassays for cyclosporine.
    Holt DW; Marsden JT; Fashola TO; Johnston A
    Transplant Proc; 1990 Jun; 22(3):1155-9. PubMed ID: 2349678
    [No Abstract]   [Full Text] [Related]  

  • 18. Simultaneous monitoring of cyclosporin in blood and plasma with four analytical methods: a clinical evaluation.
    Lindholm A; Henricsson S
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1472-4. PubMed ID: 2652471
    [No Abstract]   [Full Text] [Related]  

  • 19. Liver transplantation in Birmingham--use of cyclosporine--clinical correlations with drug measurements.
    Gunson BK; Jones SR; Buckels JA; Jain AB; McMaster P
    Transplant Proc; 1990 Jun; 22(3):1312-8. PubMed ID: 2349692
    [No Abstract]   [Full Text] [Related]  

  • 20. Specific and nonspecific monoclonal 125I-Incstar assays.
    Wong PY; Ma J
    Transplant Proc; 1990 Jun; 22(3):1166-70. PubMed ID: 2349680
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.